These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1523091)

  • 1. The assembly and structure of the fibrin clot.
    Mosesson MW
    Nouv Rev Fr Hematol (1978); 1992; 34(1):11-6. PubMed ID: 1523091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen structure and fibrin clot assembly.
    Mosesson MW
    Semin Thromb Hemost; 1998; 24(2):169-74. PubMed ID: 9579639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
    Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
    Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin: structure and interactions.
    Hermans J; McDonagh J
    Semin Thromb Hemost; 1982 Jan; 8(1):11-24. PubMed ID: 7036348
    [No Abstract]   [Full Text] [Related]  

  • 5. Human fibrinogen.
    Shafer JA; Higgins DL
    Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of fibrin clot elasticity.
    Lim BB; Lee EH; Sotomayor M; Schulten K
    Structure; 2008 Mar; 16(3):449-59. PubMed ID: 18294856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen and fibrin: scaffold proteins in hemostasis.
    Lord ST
    Curr Opin Hematol; 2007 May; 14(3):236-41. PubMed ID: 17414213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
    Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-independent effects of heparins on fibrin clot nanostructure.
    Yeromonahos C; Marlu R; Polack B; Caton F
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1320-4. PubMed ID: 22362760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
    Hoppe B
    Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.